[ad_1]
B. Riley raised their price target on Cytokinetics from $74.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday.
[ad_2]
Source link
B. Riley Issues Positive Forecast for Cytokinetics (NASDAQ:CYTK) Stock Price
Related Posts
Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Short Interest Up 30.5% in August
[ad_1] Innovative Solutions and Support, Inc. (NASDAQ:ISSC – Get Free Report) was the recipient of a large increase in short…
Energy Vault (NYSE:NRGV) Reaches New 52-Week High on Insider Buying Activity
[ad_1] Energy Vault (NYSE:NRGV) Hits New 1-Year High on Insider Buying Activity [ad_2] Source link
How major US stock indexes fared Wednesday, 9/3/2025
[ad_1] Wall Street steadied itself after Alphabet and other technology stocks rose. The S&P 500 added 0.5% Wednesday and broke…